A detailed history of Avoro Capital Advisors LLC transactions in Verrica Pharmaceuticals Inc. stock. As of the latest transaction made, Avoro Capital Advisors LLC holds 3,999,999 shares of VRCA stock, worth $31.8 Million. This represents 0.4% of its overall portfolio holdings.

Number of Shares
3,999,999
Previous 3,999,999 -0.0%
Holding current value
$31.8 Million
Previous $23.7 Million 23.14%
% of portfolio
0.4%
Previous 0.29%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 14, 2024

BUY
$2.93 - $7.32 $3.06 Million - $7.66 Million
1,045,935 Added 35.41%
3,999,999 $29.3 Million
Q2 2023

Aug 14, 2023

BUY
$5.32 - $6.79 $1.62 Million - $2.06 Million
304,064 Added 11.47%
2,954,064 $17 Million
Q1 2023

May 15, 2023

BUY
$2.88 - $8.51 $7.63 Million - $22.6 Million
2,650,000 New
2,650,000 $17.2 Million

Others Institutions Holding VRCA

About Verrica Pharmaceuticals Inc.


  • Ticker VRCA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 41,094,100
  • Market Cap $327M
  • Description
  • Verrica Pharmaceuticals Inc., a dermatology therapeutics company, develops and commercializes treatments for people with skin diseases in the United States. The company's lead product candidate includes VP-102 for the treatment of molluscum contagiosum; that has completed Phase II clinical trial for the treatment of external genital warts; and w...
More about VRCA
Track This Portfolio

Track Avoro Capital Advisors LLC Portfolio

Follow Avoro Capital Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Avoro Capital Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Avoro Capital Advisors LLC with notifications on news.